Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Targeted Agents or Immuno-Oncology Therapies as First-Line Therapy for BRAF-Mutated Metastatic Melanoma: A Real-World Study

PaperCitations, authors & open-access status

Targeted Agents or Immuno-Oncology Therapies as First-Line Therapy for BRAF-Mutated Metastatic Melanoma: A Real-World Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 38 citations, 2019 year and hybrid oa status.

38
Citations
2019
Year
hybrid
OA Status

Related on ScholarIQ

Briana Ndife
Author
Future Oncology
Journal
Melanoma and MAPK Pathways
Topic
Melanoma and MAPK Pathways
Topic
CAR-T cell therapy research
Topic
Cutaneous Melanoma Detection and Management
Topic
470M+ articles · free account